Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2515357 | Biochemical Pharmacology | 2006 | 12 Pages |
Abstract
The NF-κB family of transcription factors plays key roles in the control of cell proliferation and apoptosis. Constitutive NF-κB activation is a common feature for most haematological malignancies and is therefore believed to be a crucial event for enhanced proliferation and survival of these malignant cells. In this review, we will describe the molecular mechanisms underlying NF-κB deregulation in haematological malignancies and will highlight what is still unclear in this field, 20 years after the discovery of this transcription factor.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Aurore Keutgens, Isabelle Robert, Patrick Viatour, Alain Chariot,